News Focus
News Focus
icon url

tradeherpete

08/18/22 7:05 PM

#370967 RE: Steady_T #370954

If Anavex can improve 10 or 15% of patients, slow decline in 50 or 60%, who wouldn’t drop everything and RUN to get Blarcamesine, to find out if they could be improved?

Are you expecting people to stay on anything that does nothing when there’s something out there that could help?

There were also a lot of subjects that continued to decline albeit at a reduced rate and some that quit declining. Those results aren't going to cause "the existing supply chain" to fall apart.


Yes, it will.
icon url

jmvho

08/18/22 7:09 PM

#370968 RE: Steady_T #370954

Steady_T,

Curious as to what percentage odds you give Anavex in meeting the phase 2b/3
AD trial primary and secondary endpoints ?

TIA,

jmvho